Food and Drug Administration

Cellular, Tissue and Gene Therapies Advisory Committee

March 3, 2005

Slides

FDA Introduction, Dr. Malcolm Moos, Jr. (HTM) (PPT)

FDA Perspective on the Development of Cellular Therapies for Repair and Regeneration of Joint Surfaces - Preclinical Perspective, Dr. Richard McFarland, PhD, MD (HTM) (PPT)

Preclinical Animal Models of Cartilage Repair and Regeneration, Dr. Matthew Allen, Vet. MB, PhD, SUNNY Upstate Medical University (HTM) (PPT)

FDA Perspective on the Development of Cellular Therapies for Repair and Regeneration of Joint Surfaces - Clinical, Dr. Susan Leibenhaut (HTM) (PPT)

Perspectives on Clinical Outcomes of Studies of Products for Use in Cartilage Repair, Dr. Marc Hochberg, MD, MPH, University of MD School of Medicine (HTM) (PPT)